Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kezar Life Sciences Inc (NQ: KZR ) 7.410 -0.020 (-0.27%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 27,591 Open 7.440 Bid (Size) 7.410 (13) Ask (Size) 7.580 (12) Prev. Close 7.430 Today's Range 7.350 - 7.550 52wk Range 5.202 - 11.35 Shares Outstanding 72,407,215 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Glancy Prongay & Murray LLP Announces Investigation of Kezar Life Sciences, Inc. (KZR) November 05, 2024 From Glancy Prongay & Murray LLP Via Business Wire Looking Into Kezar Life Sciences's Recent Short Interest October 29, 2024 Via Benzinga Performance YTD -22.00% -22.00% 1 Month +0.14% +0.14% 3 Month +28.33% +28.33% 6 Month -9.30% -9.30% 1 Year -11.52% -11.52% More News Read More Kezar Life Sciences Announces 1-for-10 Reverse Stock Split October 28, 2024 From Kezar Life Sciences Via Business Wire Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study October 17, 2024 Via Benzinga Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan October 17, 2024 From Kezar Life Sciences Via Business Wire Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update October 17, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal October 10, 2024 From Kezar Life Sciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session October 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 09, 2024 Via Benzinga Why Saratoga Investment Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket October 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session October 08, 2024 Via Benzinga FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths October 07, 2024 Via Benzinga Exposures Product Safety Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis October 04, 2024 From Kezar Life Sciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session October 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session September 30, 2024 Via Benzinga Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients September 30, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Discontinues Unpromising Phase 1 Solid Tumor Drug August 14, 2024 Via Benzinga KZR Stock Earnings: Kezar Life Sciences Beats EPS for Q2 2024 August 13, 2024 Via InvestorPlace Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update August 13, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) July 10, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) June 07, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference May 29, 2024 From Kezar Life Sciences, Inc. Via Business Wire KZR Stock Earnings: Kezar Life Sciences Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Kezar Life Sciences, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
